1.800.979.8292

The Miraca Life Sciences Registry

Miraca Life Sciences Registry - Advancing Cancer Research

What is the Miraca Life Sciences Registry?

The Miraca Life Sciences Registry is a multi-center, observational outcomes database designed to collect data on the demographics, presentation, diagnosis, treatment, resource use, and outcomes of eligible patients who previously have undergone Miraca hematopoietic diagnostics testing.

By contributing patients’ data, physicians gain valuable knowledge for future patients with similar disease profiles.

Participation guidelines have been separately determined by the Miraca Registry team, pursuant to a protocol that has been approved by an independent Institutional Review Board (IRB).

How does the Miraca Life Sciences Registry work?

Detailed information from the initial hematopoietic diagnostic testing completed at Miraca and the patient’s outcome, collected and tracked over time, comprises the data that appears in the Miraca Registry. Patient outcome data is collected in three data intervals: enrollment, month 9 and month 63.

Data Collection Intervals

Who is considered an “eligible patient”?

Bone marrow and comprehensive peripheral blood cases are eligible for enrollment into the Miraca Registry if the following minimum inclusion criteria are met:

  • Morphology
  • Minimum of 3 technologies
    • IHC
    • Flow Cytometry
    • FISH
    • Cytogenetics
    • PCR
    • Sequencing

Participation in the registry is voluntary. All patients who meet the eligibility criteria above and who are seen within a participating physician practice are potential candidates for this registry.

The exclusion criteria for the Miraca Registry include the following:

  • Patients < 18 years of age
  • Prisoners

The Miraca Life Sciences Registry

Latest Research

Caris Life Sciences Molecular Oncology Services

Miraca’ scientific experts contribute to the advancement of science at various symposia and conferences worldwide.

learn more